NBW News PharmEasy Founders to Board: Not Selling Thyrocare, Will Reduce Cash Burn

News

PharmEasy Founders to Board: Not Selling Thyrocare, Will Reduce Cash Burn

February 14, 2023
7:01 AM

PharmEasy’s parent company, API Holdings, has decided not to sell Thyrocare.
This decision is intended to reduce the company’s cash burn.
Plans for a potential initial public offering (IPO) have been delayed until 2025.

Tom

You may also like

News

Moderna partners with OpenAI to integrate ChatGPT into its operations

Moderna and OpenAI have formed a partnership to incorporate AI, specifically ChatGPT, across

Perplexity’s journey: From text-to-SQL tool to a billion-dollar AI-powered search engine

Big Ideas from podcasts

Perplexity’s journey: From text-to-SQL tool to a billion-dollar AI-powered search engine

Perplexity’s journey: From text-to-SQL tool to a billion-dollar AI-powered search engine This conversation

Get the latest

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Hot news

Travel

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor

Most popular

Apple to introduce on-device LLM at WWDC 2024, aiming for privacy and performance

Moderna partners with OpenAI to integrate ChatGPT into its operations

Perplexity’s journey: From text-to-SQL tool to a billion-dollar AI-powered search engine

Perplexity’s journey: From text-to-SQL tool to a billion-dollar AI-powered search engine

EU report reveals cancer-causing pesticide in Indian exports, including organic products